Many mycotoxins are carcinogenic, while exposure to others can result in kidney damage and immunosuppressive effects. Due to the potential serious health consequences of mycotoxin exposure, many states have imposed strict limitations on the concentrations of mycotoxins allowable in medicinal cannabis products.
US Cannalytics uses industry-leading liquid chromatography tandem mass spectrometry (LC-MS/MS) technology to determine mycotoxin levels in concentrations down to parts per billion (ppb).
We are currently ISO-accredited to perform analysis on the following analytes:
|Aflatoxin B1||Aflatoxin G1|
|Aflatoxin B2||Aflatoxin G2|